TY - JOUR
T1 - Polyphenols beyond barriers
T2 - A glimpse into the brain
AU - Figueira, Inês
AU - Menezes, Regina
AU - Macedo, Diana
AU - Costa, Inês
AU - dos Santos, Cláudia Nunes
PY - 2017/5/1
Y1 - 2017/5/1
N2 - Background: Ageing can be simply defined as the process of becoming older, which is genetically determined but also environmentally modulated. With the continuous increase of life expectancy, quality of life during ageing has become one of the biggest challenges of developed countries. The quest for a healthy ageing has led to the extensive study of plant polyphenols with the aim to prevent age-associated deterioration and diseases, including neurodegenerative diseases. The world of polyphenols has fascinated researchers over the past decades, and in vitro, cell-based, animal and human studies have attempted to unravel the mechanisms behind dietary polyphenols neuroprotection. Methods: In this review, we compiled some of the extensive and ever-growing research in the field, highlighting some of the most recent trends in the area. Results: The main findings regarding polypolyphenols neuroprotective potential performed using in vitro, cellular and animal studies, as well as human trials are covered in this review. Concepts like bioavailability, polyphenols biotransformation, transport of dietary polyphenols across barriers, including the blood-brain barrier, are here explored. Conclusion: The diversity and holistic properties of polypolyphenol present them as an attractive alternative for the treatment of multifactorial diseases, where a multitude of cellular pathways are disrupted. The underlying mechanisms of polypolyphenols for nutrition or therapeutic applications must be further consolidated, however there is strong evidence of their beneficial impact on brain function during ageing. Nevertheless, only the tip of the iceberg of nutritional and pharmacological potential of dietary polyphenols is hitherto understood and further research needs to be done to fill the gaps in pursuing a healthy ageing.
AB - Background: Ageing can be simply defined as the process of becoming older, which is genetically determined but also environmentally modulated. With the continuous increase of life expectancy, quality of life during ageing has become one of the biggest challenges of developed countries. The quest for a healthy ageing has led to the extensive study of plant polyphenols with the aim to prevent age-associated deterioration and diseases, including neurodegenerative diseases. The world of polyphenols has fascinated researchers over the past decades, and in vitro, cell-based, animal and human studies have attempted to unravel the mechanisms behind dietary polyphenols neuroprotection. Methods: In this review, we compiled some of the extensive and ever-growing research in the field, highlighting some of the most recent trends in the area. Results: The main findings regarding polypolyphenols neuroprotective potential performed using in vitro, cellular and animal studies, as well as human trials are covered in this review. Concepts like bioavailability, polyphenols biotransformation, transport of dietary polyphenols across barriers, including the blood-brain barrier, are here explored. Conclusion: The diversity and holistic properties of polypolyphenol present them as an attractive alternative for the treatment of multifactorial diseases, where a multitude of cellular pathways are disrupted. The underlying mechanisms of polypolyphenols for nutrition or therapeutic applications must be further consolidated, however there is strong evidence of their beneficial impact on brain function during ageing. Nevertheless, only the tip of the iceberg of nutritional and pharmacological potential of dietary polyphenols is hitherto understood and further research needs to be done to fill the gaps in pursuing a healthy ageing.
KW - Bioavailability
KW - Blood-brain barrier
KW - Healthy ageing
KW - Neurodegenerative disorders
KW - Neuroprotection
KW - Polyphenols
UR - http://www.scopus.com/inward/record.url?scp=85019604855&partnerID=8YFLogxK
U2 - 10.2174/1570159X14666161026151545
DO - 10.2174/1570159X14666161026151545
M3 - Review article
C2 - 27784225
AN - SCOPUS:85019604855
SN - 1570-159X
VL - 15
SP - 562
EP - 594
JO - Current Neuropharmacology
JF - Current Neuropharmacology
IS - 4
ER -